MedPath

Melatonin in women with endometriosis

Phase 3
Conditions
Endometriosis of uterus.
Endometriosis
Registration Number
IRCT20170612034489N2
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
40
Inclusion Criteria

Patients aged 18-45 years old that have proven endometriosis associated chronic pelvic pain for last 6 months
Patient with menstural cycle 21-35 days
Patients with VAS score>7

Exclusion Criteria

Patients who had substance and alchohol use in past 6 months
Patients were undergoing hormonal therapy in past 3 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pelvic pain. Timepoint: Before and after 8 week of intervention. Method of measurement: A Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
se of analgesic mefenamic acid. Timepoint: Before and after 8 week of intervention. Method of measurement: Health records.
© Copyright 2025. All Rights Reserved by MedPath